Aperio Group LLC lifted its stake in shares of Albemarle Co. (NYSE:ALB) by 7.0% in the 4th quarter, HoldingsChannel reports. The fund owned 42,819 shares of the specialty chemicals company’s stock after acquiring an additional 2,788 shares during the quarter. Aperio Group LLC’s holdings in Albemarle were worth $5,476,000 as of its most recent SEC filing.

Several other hedge funds also recently modified their holdings of ALB. Thrivent Financial For Lutherans increased its position in shares of Albemarle by 2.2% during the second quarter. Thrivent Financial For Lutherans now owns 4,240 shares of the specialty chemicals company’s stock worth $447,000 after acquiring an additional 90 shares in the last quarter. Ark Investment Management LLC increased its position in shares of Albemarle by 104.6% during the second quarter. Ark Investment Management LLC now owns 6,368 shares of the specialty chemicals company’s stock worth $672,000 after acquiring an additional 3,255 shares in the last quarter. QS Investors LLC increased its position in shares of Albemarle by 24.1% during the second quarter. QS Investors LLC now owns 4,630 shares of the specialty chemicals company’s stock worth $489,000 after acquiring an additional 900 shares in the last quarter. Balyasny Asset Management LLC bought a new stake in shares of Albemarle during the second quarter worth $852,000. Finally, The Manufacturers Life Insurance Company increased its position in shares of Albemarle by 9.2% during the second quarter. The Manufacturers Life Insurance Company now owns 125,549 shares of the specialty chemicals company’s stock worth $13,252,000 after acquiring an additional 10,625 shares in the last quarter. 87.38% of the stock is owned by institutional investors.

ALB has been the subject of several research reports. Jefferies Group increased their price objective on shares of Albemarle from $156.00 to $162.00 and gave the stock a “buy” rating in a research report on Tuesday, November 14th. Royal Bank of Canada reaffirmed a “buy” rating and issued a $149.00 target price on shares of Albemarle in a research report on Wednesday, October 18th. Zacks Investment Research raised shares of Albemarle from a “hold” rating to a “buy” rating and set a $157.00 target price for the company in a research report on Tuesday, October 17th. Loop Capital set a $150.00 target price on shares of Albemarle and gave the company a “buy” rating in a research report on Tuesday, December 19th. Finally, Oppenheimer reaffirmed a “buy” rating on shares of Albemarle in a research report on Wednesday, January 17th. Ten investment analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the company. The company presently has an average rating of “Buy” and an average price target of $127.88.

Shares of Albemarle Co. (NYSE:ALB) opened at $108.45 on Wednesday. The company has a market cap of $11,980.00, a price-to-earnings ratio of 38.73, a price-to-earnings-growth ratio of 1.42 and a beta of 1.56. The company has a debt-to-equity ratio of 0.35, a current ratio of 2.11 and a quick ratio of 1.56. Albemarle Co. has a 12 month low of $90.35 and a 12 month high of $144.99.

TRADEMARK VIOLATION NOTICE: “Aperio Group LLC Raises Stake in Albemarle Co. (ALB)” was posted by TheOlympiaReport and is the property of of TheOlympiaReport. If you are accessing this piece on another website, it was illegally stolen and republished in violation of U.S. and international trademark and copyright law. The correct version of this piece can be read at https://theolympiareport.com/2018/02/14/aperio-group-llc-raises-stake-in-albemarle-co-alb.html.

About Albemarle

Albemarle Corporation is a global developer, manufacturer and marketer of highly-engineered specialty chemicals. The Company operates through three segments: Lithium and Advanced Materials, Bromine Specialties and Refining Solutions. Lithium and Advanced Materials segment consist of two product categories: Lithium and Performance Catalyst Solutions.

Want to see what other hedge funds are holding ALB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Albemarle Co. (NYSE:ALB).

Institutional Ownership by Quarter for Albemarle (NYSE:ALB)

Receive News & Ratings for Albemarle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Albemarle and related companies with MarketBeat.com's FREE daily email newsletter.